Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 203093 / DOSAGE - TABLET;ORAL - 150MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| ELVITEGRAVIR(UNII: 4GDQ854U53) (ELVITEGRAVIR - UNII:4GDQ854U53) | ELVITEGRAVIR | 150mg | 85mg |
Inactive Ingredients
| Ingredient Name | Gilead Sciences, Inc. |
|---|---|
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |
| CROSCARMELLOSE SODIUM(M28OL1HH48) | |
| FD&C BLUE NO. 2(L06K8R7DQK) | |
| FERRIC OXIDE YELLOW(EX438O2MRT) | |
| HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P) | |
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |
| MAGNESIUM STEARATE(70097M6I30) | |
| POLYETHYLENE GLYCOL 3350(G2M7P15E5P) | |
| POLYVINYL ALCOHOL(532B59J990) | |
| SODIUM LAURYL SULFATE(368GB5141J) | |
| TALC(7SEV7J4R1U) | |
| TITANIUM DIOXIDE(15FIX9V2JP) | |
| WATER(059QF0KO0R) |
